AU9024591A - Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders - Google Patents
Biphenylalkyl xanthine compounds for treatment of cardiovascular disordersInfo
- Publication number
- AU9024591A AU9024591A AU90245/91A AU9024591A AU9024591A AU 9024591 A AU9024591 A AU 9024591A AU 90245/91 A AU90245/91 A AU 90245/91A AU 9024591 A AU9024591 A AU 9024591A AU 9024591 A AU9024591 A AU 9024591A
- Authority
- AU
- Australia
- Prior art keywords
- biphenylalkyl
- treatment
- cardiovascular disorders
- xanthine compounds
- xanthine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60365390A | 1990-10-25 | 1990-10-25 | |
US603653 | 1990-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9024591A true AU9024591A (en) | 1992-05-26 |
Family
ID=24416375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU90245/91A Abandoned AU9024591A (en) | 1990-10-25 | 1991-10-16 | Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU9024591A (en) |
CA (1) | CA2055129A1 (en) |
WO (1) | WO1992007852A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU653364B2 (en) * | 1990-09-26 | 1994-09-29 | Beecham Group Plc | Xanthine derivatives |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990095A (en) | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
SE9903028D0 (en) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them |
IL96019A0 (en) * | 1989-10-31 | 1991-07-18 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
EP0430300A3 (en) * | 1989-12-01 | 1992-03-25 | Takeda Chemical Industries, Ltd. | Xanthine derivatives, their production and use |
-
1991
- 1991-10-16 WO PCT/US1991/007426 patent/WO1992007852A1/en active Application Filing
- 1991-10-16 AU AU90245/91A patent/AU9024591A/en not_active Abandoned
- 1991-11-07 CA CA002055129A patent/CA2055129A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU653364B2 (en) * | 1990-09-26 | 1994-09-29 | Beecham Group Plc | Xanthine derivatives |
Also Published As
Publication number | Publication date |
---|---|
WO1992007852A1 (en) | 1992-05-14 |
CA2055129A1 (en) | 1992-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4525396A (en) | Process for the preparation of perfluorocarbons | |
AU7903091A (en) | N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders | |
AU9024591A (en) | Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders | |
EP0510503A3 (en) | Process for the treatment of surfaces | |
HU9301985D0 (en) | Process for the preparation of wort | |
GB9323088D0 (en) | Novel process for the preparation of benzylformimidate | |
EP0523671A3 (en) | Process for the preparation of chlorofluoronitrobenzenes | |
AU1142192A (en) | Process for the preparation of 13c-labelled compounds | |
AU8463691A (en) | Processes for the preparation of nitrogen-containing compounds | |
HUT69309A (en) | Process for the preparation of 2-alkoxymethyl-acrolein | |
AU8457591A (en) | Process for the preparation of carbapenem compounds | |
AU8516891A (en) | Acid treatment for decaffeination of coffee | |
AU8251891A (en) | Process for the preparation of 1-alkylisoquinoline derivatives | |
AU1235992A (en) | Process for separation of two solid components | |
EP0518013A3 (en) | Process for the preparation of 1-alkoxy-2-dialkylaminoethanes | |
AU8036291A (en) | Process for the preparation of 1-hydroxymethylpyrazoles | |
AU2297192A (en) | Optically pure s(-) nadolol for treatment of cardiovascular disorders | |
EP0537589A3 (en) | Process for the preparation of dinitro- and diaminophenoxy compounds | |
ZA925371B (en) | Process for the preparation of 17-substituted-4-aza-5-androstan-3-one | |
AU2875092A (en) | Methods for the treatment of hyperlipidemia using azaspiranes | |
EP0523619A3 (en) | Process for the preparation of n-cyanimidocarbonates | |
EP0523668A3 (en) | Process for the preparation of difluorobenzaldehydes | |
AU1306992A (en) | Process for the preparation of n-alkylsufonamides | |
AU640818B2 (en) | Process for the preparation of aminopyrimidines | |
AU1294792A (en) | Process for the realization of binding elements |